查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1239488

內窺鏡流體管理市場：按產品、應用、最終用戶分類：2021-2031 年全球機遇分析和行業預測

Endoscopy Fluid Management Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 399 Pages | 商品交期: 2-3個工作天內

價格

2021 年內窺鏡流體管理市場價值 6.4064 億美元，2022-2031 年的複合年增長率為 7.2%，預計到 2031 年將達到 12.864 億美元。

內窺鏡流體管理系統被定義為用於提高內窺鏡手術過程中可見度的醫療設備。 它通過向管腔施加流體壓力、擴大手術區域以及清潔碎屑和血液來工作。 一些內窺鏡手術使用沖洗液。 內窺鏡檢查是為正確診斷和檢測疾病而執行的程序。 內窺鏡流體管理系統廣泛用於各種內窺鏡手術，包括腹腔鏡、宮腔鏡、關節鏡和泌尿外科。

內窺鏡流體管理系統市場的增長還受到各種內窺鏡流體管理系統設備開發技術進步、腹腔鏡手術數量增加以及微創手術需求激增的推動。下降。 此外，越來越多的人患有胃食管反流病 (GERD) 也有望增加對內窺鏡檢查流體管理系統的需求並推動市場增長。 根據食道年鑑，到 2022 年，每年將有大約 60 至 7000 萬美國人被診斷出患有胃腸道疾病。 胃食管反流病 (GERD) 是最常見的胃腸道疾病之一。 因此，越來越多的人患有 GERD、關節疾病和異常子宮出血，導致對內窺鏡手術的需求不斷增加。 因此，對用於內窺鏡檢查的流體管理系統的需求不斷增長。 BMC Women's Health 報告稱，到 2020 年，大約 10% 到 30% 的育齡婦女將被診斷為異常子宮出血。

例如，2021 年 1 月，創新醫療技術公司 Hologic 宣佈在歐洲推出流體管理系統。 該產品旨在為進行宮腔鏡手術的醫生提供更有效的液體管理。 這樣，新興國家正在開發先進流體管理產品的市場，並有望促進市場增長。 此外，對疾病早期診斷以進行有效治療的需求不斷增長，這是全球市場擴張的主要驅動力。

此外，可支配收入的增加以及製造先進流體管理系統設備的主要參與者數量的增加預計將創造有利可圖的增長機會，從而推動內窺鏡流體管理市場的增長。 據說老年人更容易患關節病。 因此，不斷增長的老年人口和對關節病手術的需求激增進一步推動了對內窺鏡流體管理系統的需求。 例如，Eclinical Medicine 報告稱，到 2020 年，約 22% 的 40 歲以上的成年人將患有膝骨關節炎。

此外，政府增加用於發展醫療保健基礎設施的支出正在推動市場的增長。 例如，2022 年 10 月，美國農業部 (USDA) 農村發展部將投資約 246 萬美元，以改善居住在美國弗吉尼亞州農村地區的人們獲得食品分配和醫療保健基礎設施的機會。。 政府還將投資於現代化和改善該國的醫療基礎設施，並提高醫療質量。 此外，政府將提供額外資金支持醫學研究，並為醫學院校和教學醫院提供財政支持。 因此，預計全球醫療保健支出的增加將推動對內窺鏡流體管理系統的需求並促進市場增長。

但是，與內窺鏡檢查流體管理系統相關的高成本以及與使用流體管理系統相關的副作用（例如噁心、腹部不適和脫水）預計會阻礙市場增長。 現代人對自己的健康意識很強，因此，他們被迫保持健康狀態，這增加了對診斷設備的需求。 在此背景下，許多主要參與者進入了新興市場，為場外檢測市場提供了有利可圖的增長機會。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要影響因素
    • 主要投資領域
  • 波特的五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 中等強度的競爭
  • 市場動態
    • 司機
      • 對微創手術的需求不斷增加
      • 需要內窺鏡檢查的慢性病患病率增加
      • 醫療器械行業研發活動的成熟度
    • 約束因素
      • 內窺鏡手術費用高
    • 機會
      • 增加內窺鏡輸液管理系統的主要製造商
  • 分析 COVID-19 對市場的影響

第 4 章內窺鏡流體管理市場：按產品分類

  • 概覽
    • 市場規模和預測
  • 內窺鏡流體管理系統
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 內窺鏡流體管理配件
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章內窺鏡流體管理市場：按應用

  • 概覽
    • 市場規模和預測
  • 腹腔鏡檢查
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 宮腔鏡檢查
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章內窺鏡流體管理市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 醫務室
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章內窺鏡流體管理市場：按地區

  • 概覽
    • 市場規模和預測：按地區
  • 北美
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
  • 歐洲
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 其他歐洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
  • 亞太地區
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 其他亞太地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
  • 拉丁美洲/中東/非洲
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 其他拉丁美洲/中東/非洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測

第八章競爭格局

  • 介紹
  • 關鍵成功策略
  • 排名前 10 位的玩家產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 2021 年最佳球員排名

第九章公司簡介

  • Medtronic plc
  • Olympus america inc
  • KARL STORZ SE & Co. KG
  • Stryker Corporation
  • Hologic Inc.
  • Arthrex, Inc.
  • CONMED Corporation
  • COMEG medical technologies
  • STERIS plc
  • B. Braun SE
Product Code: A10966

The Endoscopy Fluid Management Market valued for $640.64 million in 2021 and is estimated to reach $1,286.4 million by 2031, exhibiting a CAGR of 7.2% from 2022 to 2031. The endoscopic fluid management system is defined as the medical device which is used to enhance visibility during endoscopic procedure. It acts by providing fluid pressure to the internal cavities, dilating the operating area, and washing the debris and blood. Some of the endoscopic surgical procedures involve the use of irrigating fluids. Endoscopy is a procedure which is conducted for proper diagnosis, and detection of disease. Endoscopy fluid management system is widely used for various endoscopic surgical procedure such as laparoscopy, hysteroscopy, arthroscopy, and urology.

The growth of endoscopy fluid management market is driven by technological advancement for development of different endoscopy fluid management systems devices, rise in the number of laparoscopy procedures, and surge in demand for minimal invasive surgical procedure. In addition, rise in the number of people suffering from gastroesophageal reflux disease (GERD) is anticipated to fuel the demand for endoscopy fluid management systems and drive the growth of market. According to the Journal of Annals of Esophagus, in 2022, around 60 to 70 million American population were reported to have been diagnosed with gastrointestinal disease, every year. Gastroesophageal reflux disease (GERD) is one of the most commonly diagnosed gastrointestinal disease. Thus, rise in population suffering from GERD, joint disease, and abnormal uterine bleeding is attributed to increase the demand for endoscopy procedure. This boosts the need of endoscopy fluid management system. According to the Journal of BMC Women's Health, in 2020, approximately 10% to 30% of women in reproductive age were reported to have been diagnosed with abnormal uterine bleeding.

For instance, in January 2021, the Hologic, Inc., an innovative medical technology company, announced the launch of fluent fluid management system, in Europe. This product is designed to offers more effective fluid management for physician in hysteroscopic procedures. Thus, increase in development of advanced fluid management products in emerging nations are expected to propel the growth of the market. In addition, the rise in demand for early diagnosis of disease for effective treatment acts a key driving force for the expansion of the global market.

Moreover, increase in disposable income, and rise in number of key players to manufacturer advanced fluid management system devices are expected to create lucrative growth opportunities to drive the growth of the endoscopy fluid management market. In addition, geriatric population is susceptible to joint diseases. Thus, rise in number of geriatric population, surge in need for arthropathy procedure, which further fuel the demand for endoscopic fluid management system. For instance, according to EclinicalMedicine, in 2020, it was reported that around 22% of adult above the age of 40 years have knee osteoarthritis.

Furthermore, rise in expenditure by government to develop healthcare infrastructure fuels the market growth. For instance, in October 2022, U.S. Department of Agriculture (USDA) rural development invests around $2.46 million to increase access to food distribution and healthcare infrastructure for population living in rural Virginia, U.S. In addition, the government is likely to invest in modernizing and improving the nation's healthcare infrastructure, and improve the quality of care. Furthermore, the government is likely to invest in providing additional funding to support medical research, and providing financial support for medical schools and teaching hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for endoscopy fluid management system, thereby boosting the market growth.

However, high cost associated with endoscopic fluid management systems and side effect associated with the use of fluid management system such as nausea, abdominal discomfort, and dehydration are anticipated to hinder the market growth. Now-a-day, population are aware of health, which in turn is compelling them to maintain their health condition and increase the demand for diagnosis devices. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the over-the-counter tests market.

The global endoscopy fluid management system market is segmented into product, application, and end user. On the basis of product, the market is divided into endoscopy fluid management system, and endoscopy fluid management accessories. On the basis of application, the market is divided into laparoscopy, hysteroscopy, and others. The others include arthroscopy, and urology. On the basis of end user, the market is divided into hospitals, clinics and others. The others segment includes ambulatory surgical center, physician practices, diagnostic centers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global medical exoskeleton market include: Medtronic, Olympus America, Karl Storz Se & Co. Kg, Stryker, Hologic Inc, Arthrex, Inc, B. Braun, Cantel, COMEG, and CONMED Corporation

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the endoscopy fluid management market analysis from 2021 to 2031 to identify the prevailing endoscopy fluid management market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the endoscopy fluid management market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global endoscopy fluid management market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Endoscopy fluid management system
  • Endoscopy fluid management accessories

By Application

  • Laparoscopy
  • Hysteroscopy
  • Others

By End User

  • Hospital
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Medtronic plc
  • STERIS plc
  • KARL STORZ SE & Co. KG
  • Arthrex, Inc.
  • B. Braun SE
  • Stryker Corporation
  • Hologic Inc.
  • CONMED Corporation
  • Olympus america inc
  • COMEG medical technologies

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate threat of new entrants
    • 3.3.5. Moderate intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the demand for minimally invasive surgeries
      • 3.4.1.2. Increase in the prevalence of chronic disease that require endoscopy procedure
      • 3.4.1.3. Advancement in R&D activities in medical device industry
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of endoscopic procedure
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in the number of key players to manufacture endoscopic fluid management systems
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Endoscopy fluid management system
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Endoscopy fluid management accessories
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Laparoscopy
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Hysteroscopy
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospital
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Clinics
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: ENDOSCOPY FLUID MANAGEMENT MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Product
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Product
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Product
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Product
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Product
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Product
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Product
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Product
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Product
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Product
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Product
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Product
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Product
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Product
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Product
      • 7.4.5.6.3. Market size and forecast, by Application
      • 7.4.5.6.4. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Product
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Product
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Product
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Product
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Medtronic plc
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Olympus america inc
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. KARL STORZ SE & Co. KG
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Stryker Corporation
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Hologic Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Arthrex, Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. CONMED Corporation
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. COMEG medical technologies
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. STERIS plc
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. B. Braun SE
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. ENDOSCOPY FLUID MANAGEMENT MARKET FOR ENDOSCOPY FLUID MANAGEMENT SYSTEM, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. ENDOSCOPY FLUID MANAGEMENT MARKET FOR ENDOSCOPY FLUID MANAGEMENT ACCESSORIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. ENDOSCOPY FLUID MANAGEMENT MARKET FOR LAPAROSCOPY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. ENDOSCOPY FLUID MANAGEMENT MARKET FOR HYSTEROSCOPY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. ENDOSCOPY FLUID MANAGEMENT MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. ENDOSCOPY FLUID MANAGEMENT MARKET FOR HOSPITAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. ENDOSCOPY FLUID MANAGEMENT MARKET FOR CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. ENDOSCOPY FLUID MANAGEMENT MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. ENDOSCOPY FLUID MANAGEMENT MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. U.S. ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. U.S. ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. U.S. ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. CANADA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. CANADA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. MEXICO ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. MEXICO ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. GERMANY ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. GERMANY ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. GERMANY ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. FRANCE ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. FRANCE ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. FRANCE ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. UK ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. UK ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. UK ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. ITALY ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. ITALY ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ITALY ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. SPAIN ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. SPAIN ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. SPAIN ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. REST OF EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. REST OF EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. REST OF EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. JAPAN ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. JAPAN ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. INDIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. INDIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. INDIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. AUSTRALIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. AUSTRALIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. AUSTRALIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. SOUTH KOREA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. SOUTH KOREA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. SOUTH KOREA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. BRAZIL ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. BRAZIL ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. BRAZIL ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. SAUDI ARABIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. SAUDI ARABIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. SAUDI ARABIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. SOUTH AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. SOUTH AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. REST OF LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. REST OF LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. REST OF LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 87. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 88. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 89. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 90. OLYMPUS AMERICA INC: KEY EXECUTIVES
  • TABLE 91. OLYMPUS AMERICA INC: COMPANY SNAPSHOT
  • TABLE 92. OLYMPUS AMERICA INC: PRODUCT SEGMENTS
  • TABLE 93. OLYMPUS AMERICA INC: PRODUCT PORTFOLIO
  • TABLE 94. KARL STORZ SE & CO. KG: KEY EXECUTIVES
  • TABLE 95. KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
  • TABLE 96. KARL STORZ SE & CO. KG: PRODUCT SEGMENTS
  • TABLE 97. KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
  • TABLE 98. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 99. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 100. STRYKER CORPORATION: PRODUCT SEGMENTS
  • TABLE 101. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 102. HOLOGIC INC.: KEY EXECUTIVES
  • TABLE 103. HOLOGIC INC.: COMPANY SNAPSHOT
  • TABLE 104. HOLOGIC INC.: PRODUCT SEGMENTS
  • TABLE 105. HOLOGIC INC.: PRODUCT PORTFOLIO
  • TABLE 106. HOLOGIC INC.: KEY STRATERGIES
  • TABLE 107. ARTHREX, INC.: KEY EXECUTIVES
  • TABLE 108. ARTHREX, INC.: COMPANY SNAPSHOT
  • TABLE 109. ARTHREX, INC.: PRODUCT SEGMENTS
  • TABLE 110. ARTHREX, INC.: PRODUCT PORTFOLIO
  • TABLE 111. CONMED CORPORATION: KEY EXECUTIVES
  • TABLE 112. CONMED CORPORATION: COMPANY SNAPSHOT
  • TABLE 113. CONMED CORPORATION: PRODUCT SEGMENTS
  • TABLE 114. CONMED CORPORATION: PRODUCT PORTFOLIO
  • TABLE 115. COMEG MEDICAL TECHNOLOGIES: KEY EXECUTIVES
  • TABLE 116. COMEG MEDICAL TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 117. COMEG MEDICAL TECHNOLOGIES: PRODUCT SEGMENTS
  • TABLE 118. COMEG MEDICAL TECHNOLOGIES: PRODUCT PORTFOLIO
  • TABLE 119. STERIS PLC: KEY EXECUTIVES
  • TABLE 120. STERIS PLC: COMPANY SNAPSHOT
  • TABLE 121. STERIS PLC: PRODUCT SEGMENTS
  • TABLE 122. STERIS PLC: PRODUCT PORTFOLIO
  • TABLE 123. B. BRAUN SE: KEY EXECUTIVES
  • TABLE 124. B. BRAUN SE: COMPANY SNAPSHOT
  • TABLE 125. B. BRAUN SE: PRODUCT SEGMENTS
  • TABLE 126. B. BRAUN SE: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN ENDOSCOPY FLUID MANAGEMENT MARKET (2022-2031)
  • FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALENDOSCOPY FLUID MANAGEMENT MARKET
  • FIGURE 10. ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR ENDOSCOPY FLUID MANAGEMENT SYSTEM, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR ENDOSCOPY FLUID MANAGEMENT ACCESSORIES, BY COUNTRY 2021-2031(%)
  • FIGURE 13. ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR LAPAROSCOPY, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR HYSTEROSCOPY, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 17. ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR HOSPITAL, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR CLINICS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 21. ENDOSCOPY FLUID MANAGEMENT MARKET BY REGION, 2021
  • FIGURE 22. U.S. ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 23. CANADA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. MEXICO ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. GERMANY ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. FRANCE ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. UK ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. ITALY ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. SPAIN ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. REST OF EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. JAPAN ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. INDIA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. AUSTRALIA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. SOUTH KOREA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. REST OF ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. BRAZIL ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. SAUDI ARABIA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SOUTH AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. REST OF LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45. COMPETITIVE DASHBOARD
  • FIGURE 46. COMPETITIVE HEATMAP: ENDOSCOPY FLUID MANAGEMENT MARKET
  • FIGURE 47. TOP PLAYER POSITIONING, 2021
  • FIGURE 48. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 50. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 51. OLYMPUS AMERICA INC: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 52. OLYMPUS AMERICA INC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 53. OLYMPUS AMERICA INC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 54. STRYKER CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 55. STRYKER CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 56. STRYKER CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 57. HOLOGIC INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. HOLOGIC INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. HOLOGIC INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. CONMED CORPORATION: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 61. CONMED CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 62. CONMED CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 63. STERIS PLC: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 64. STERIS PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 65. STERIS PLC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 66. B. BRAUN SE: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 67. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 68. B. BRAUN SE: REVENUE SHARE BY REGION, 2021 (%)